7476 - 7500 of 7916 Results
Title
Year
- Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine Model2011OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 29
-
OPENTitle: A soluble α-synuclein construct forms a dynamic tetramerJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 108Issue #: 43Start Page: 17797End Page: 17802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1113260108Best OA location URL: https://europepmc.org/articles/pmc3203798?pdf=renderCitation Count: 428
-
OPENTitle: Neuroprotective activities of regulatory T cellsJournal Name: Trends in Molecular MedicinePublisher: Elsevier BVVol: 17Issue #: 12Start Page: 687End Page: 688Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molmed.2011.08.005Best OA location URL: https://europepmc.org/articles/pmc5892451?pdf=renderCitation Count: 48
- Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator2011OPENTitle: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulatorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 21Issue #: 23Start Page: 6955End Page: 6959Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131Best OA location URL: https://europepmc.org/articles/pmc3319082?pdf=renderCitation Count: 16
- Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data2011OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://europepmc.org/articles/pmc4587763?pdf=renderCitation Count: 47
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qBest OA location URL: https://europepmc.org/articles/pmc3226828?pdf=renderCitation Count: 58
-
RESTRICTEDTitle: α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 63Issue #: 4Start Page: 938End Page: 966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pr.110.003269Best OA location URL: https://europepmc.org/articles/pmc3186078?pdf=renderCitation Count: 171
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
OPENTitle: Plasticity in Early Alzheimer DiseaseJournal Name: Topics in Geriatric RehabilitationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 27Issue #: 4Start Page: 257End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/tgr.0b013e31821e588eBest OA location URL: https://europepmc.org/articles/pmc3419487?pdf=renderCitation Count: 36
-
RESTRICTEDTitle: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxinsJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 563End Page: 566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019Best OA location URL: https://europepmc.org/articles/pmc3200477?pdf=renderCitation Count: 15
- Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders2011RESTRICTEDTitle: Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disordersJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 82Issue #: 8Start Page: 873End Page: 882Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2011.06.001Best OA location URL: https://europepmc.org/articles/pmc3264546?pdf=renderCitation Count: 78
-
OPENTitle: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's diseaseJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 32Issue #: 5Start Page: 640End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002Best OA location URL: https://doi.org/10.1016/j.neuro.2011.04.002Citation Count: 53
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://europepmc.org/articles/pmc3302577?pdf=renderCitation Count: 125
-
OPENTitle: GFAP mutations, age at onset, and clinical subtypes in Alexander diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 77Issue #: 13Start Page: 1287End Page: 1294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182309f72Best OA location URL: https://europepmc.org/articles/pmc3179649?pdf=renderCitation Count: 207
-
OPENTitle: Subthalamic nucleus stimulation reverses mediofrontal influence over decision thresholdJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 11Start Page: 1462End Page: 1467Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.2925Best OA location URL: https://europepmc.org/articles/pmc3394226?pdf=renderCitation Count: 608
- Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study2011OPENTitle: Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker StudyJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2283End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23934Best OA location URL: https://europepmc.org/articles/pmc3337217?pdf=renderCitation Count: 22
- BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response2011OPENTitle: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein responseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 30Issue #: 21Start Page: 4465End Page: 4478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/emboj.2011.318Best OA location URL: https://europepmc.org/articles/pmc3230375?pdf=renderCitation Count: 111
-
OPENTitle: Impaired Economy of Gait and Decreased Six-Minute Walk Distance in Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2012Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/241754Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/241754.pdfCitation Count: 35
- Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress2011OPENTitle: Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stressJournal Name: Free Radical Biology and MedicinePublisher: Elsevier BVVol: 51Issue #: 11Start Page: 2007End Page: 2017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2011.08.030Best OA location URL: https://europepmc.org/articles/pmc3208787?pdf=renderCitation Count: 181
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study2011OPENTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: https://research-repository.griffith.edu.au/bitstream/10072/43372/1/MellickPUB8.pdfCitation Count: 305
-
RESTRICTEDTitle: Drug Targets from Genetics: Alpha-SynucleinJournal Name: CNS & Neurological Disorders - Drug TargetsPublisher: Bentham Science Publishers Ltd.Vol: 10Issue #: 6Start Page: 712End Page: 723Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/187152711797247867Best OA location URL: https://europepmc.org/articles/pmc3364517?pdf=renderCitation Count: 10
-
OPENTitle: Familial Aggregation of Panic Disturbances in Parkinson's DiseaseJournal Name: Journal of NeuropsychiatryPublisher: American Psychiatric Association PublishingVol: 23Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.23.4.417Best OA location URL: https://europepmc.org/articles/pmc3547673?pdf=renderCitation Count: 1
-
OPENTitle: Translation Initiator EIF4G1 Mutations in Familial Parkinson DiseaseJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 89Issue #: 3Start Page: 398End Page: 406Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2011.08.009Best OA location URL: http://www.cell.com/article/S0002929711003594/pdfCitation Count: 273
- A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease2011RESTRICTEDTitle: A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 45Issue #: 1Start Page: 305End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.08.014Citation Count: 128
-
OPENTitle: Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locusJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/ncomms1453Best OA location URL: https://www.nature.com/articles/ncomms1453.pdfCitation Count: 425